C12Y 114/11
Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen
Official title: with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
C12Y114/11 (Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen) appears on 216 US grants and 383 published applications in this corpus.
Search patents in C12Y- Granted patents
- 216
- Published applications
- 383
- Assignees
- 172
- Inventors
- 704
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 11 |
| 2003 | 1 | 2 |
| 2004 | 6 | 3 |
| 2005 | 1 | 3 |
| 2006 | 3 | 3 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 7 |
| 2010 | 1 | 10 |
| 2011 | 2 | 5 |
| 2012 | 1 | 8 |
| 2013 | 3 | 16 |
| 2014 | 6 | 12 |
| 2015 | 4 | 19 |
| 2016 | 9 | 20 |
| 2017 | 17 | 24 |
| 2018 | 19 | 30 |
| 2019 | 21 | 25 |
| 2020 | 21 | 25 |
| 2021 | 20 | 28 |
| 2022 | 8 | 35 |
| 2023 | 17 | 24 |
| 2024 | 12 | 26 |
| 2025 | 12 | 28 |
| 2026 | 18 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 114/11002Procollagen-proline dioxygenase , i.e. proline-hydroxylase56
- C12Y 114/11004Procollagen-lysine 5-dioxygenase , i.e. lysine-hydroxylase16
- C12Y 114/11016Peptide-aspartate beta-dioxygenase , i.e. aspartyl beta-hydroxylase11
- C12Y 114/11027[histone h3]-lysine-36 demethylase11
- C12Y 114/11033Dna oxidative demethylase9
- C12Y 114/11022Flavone synthase7
- C12Y 114/11013Gibberellin 2-beta-dioxygenase5
- C12Y 114/11015Gibberellin 3-beta-dioxygenase5
All 35 subgroupsShow fewer
- C12Y 114/11009Flavanone 3-dioxygenase , i.e. naringenin-3-dioxygenase4
- C12Y 114/11012Gibberellin-44 dioxygenase4
- C12Y 114/11028Proline 3-hydroxylase4
- C12Y 114/11017Taurine dioxygenase3
- C12Y 114/11023Flavonol synthase3
- C12Y 114/1103Hypoxia-inducible factor-asparagine dioxygenase3
- C12Y 114/11031Thebaine 6-o-demethylase3
- C12Y 114/11006Thymine dioxygenase2
- C12Y 114/11007Procollagen-proline 3-dioxygenase2
- C12Y 114/11032Codeine 3-o-demethylase2
- C12Y 114/11011Hyoscyamine -dioxygenase1
- C12Y 114/11026Deacetoxycephalosporin-c hydroxylase1
- C12Y 114/11029Hypoxia-inducible factor-proline dioxygenase1
- C12Y 114/11001Gamma-butyrobetaine dioxygenase0
- C12Y 114/11003Pyrimidine-deoxynucleoside 2'-dioxygenase0
- C12Y 114/11008Trimethyllysine dioxygenase0
- C12Y 114/1101Pyrimidine-deoxynucleoside 1'-dioxygenase0
- C12Y 114/110146-beta-hydroxyhyoscyamine epoxidase0
- C12Y 114/11018Phytanoyl-coa dioxygenase0
- C12Y 114/11019Leucocyanidin oxygenase0
- C12Y 114/1102Deacetoxyvindoline 4-hydroxylase0
- C12Y 114/11021Clavaminate synthase0
- C12Y 114/110242'-deoxymugineic-acid 2'-dioxygenase0
- C12Y 114/11025Mugineic-acid 3-dioxygenase0
- C12Y 114/110342-oxoglutarate/l-arginine monooxygenase/decarboxylase0
- C12Y 114/110351-deoxypentalenic acid 11beta-hydroxylase0
- C12Y 114/11036Pentalenolactone f synthase0
Recent patents
- Transformed plant having blue flower color, and method for creating same29 Sep 2026US 12,747,447 B2Suntory Holdings Limited
- Herbicide-tolerant genes and method for using same29 Sep 2026US 12,747,449 B2Qingdao Kingagroot Chemical Compound Co., Ltd.
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Diagnosis, prognosis and treatment of malignant neoplasms29 Sep 2026US 12,748,114 B2Rhode Island Hospital
- Recombinant host cells with improved production of tetraketide derivatives22 Sep 2026US 12,742,189 B2Iptector Assets Aps
- Engineered tet enzymes and use in epigenetics and next generation sequencing (ngs), such as tet-assisted pyridine borane sequencing (taps)1 Oct 2026US 2026/0297543 A1Exact Sciences Innovation LTD.
- Process for making flavanone derivatives24 Sep 2026US 2026/0286408 A1
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Coumarin synthesis and uses thereof17 Sep 2026US 2026/0275368 A1BASF SE
- Compositions and Methods for Analyzing Modified Nucleotides3 Sep 2026US 2026/0258479 A1New England Biolabs, Inc.
Most cited
By later US patents
- Increasing specificity for RNA-guided genome editing95US 9,885,033 B2The General Hospital Corporation · 2018
- Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing87US 9,567,604 B2The General Hospital Corporation · 2017
- CAS9 proteins including ligand-dependent inteins85US 10,077,453 B2President and Fellows of Harvard College · 2018
- Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing85US 9,567,603 B2The General Hospital Corporation · 2017
- CAS9 proteins including ligand-dependent inteins57US 10,704,062 B2President and Fellows of Harvard College · 2020